Tolerability and activity of ublituximab, umbralisib, and ibrutinib in patients with chronic lymphocytic leukaemia and non-Hodgkin lymphoma: a phase 1 dose escalation and expansion trial
Titel:
Tolerability and activity of ublituximab, umbralisib, and ibrutinib in patients with chronic lymphocytic leukaemia and non-Hodgkin lymphoma: a phase 1 dose escalation and expansion trial
Auteur:
Nastoupil, Loretta J Lunning, Matthew A Vose, Julie M Schreeder, Marshall T Siddiqi, Tanya Flowers, Christopher R Cohen, Jonathon B Burger, Jan A Wierda, William G O'Brien, Susan Sportelli, Peter Miskin, Hari P Purdom, Michelle A Weiss, Michael S Fowler, Nathan H